 Heubach Colorants India Ltd Q2 FY2026 PAT at Rs. 16.28 crores
Heubach Colorants India Ltd Q2 FY2026 PAT at Rs. 16.28 crores Indiabulls Ltd Q2 FY2025-26 consolidated profit at Rs. 0.71 crore
Indiabulls Ltd Q2 FY2025-26 consolidated profit at Rs. 0.71 crore LKP Securities Ltd consolidated Q2FY26 PAT lower at Rs. 2.66 crore
LKP Securities Ltd consolidated Q2FY26 PAT lower at Rs. 2.66 crore NTPC Green Energy Ltd Signs MoU with CtrlS Datacenter Limited for development of RE Projects
NTPC Green Energy Ltd Signs MoU with CtrlS Datacenter Limited for development of RE Projects Lemon Tree Hotels signs 11th property in Punjab
Lemon Tree Hotels signs 11th property in Punjab 
              SBI Funds Management Pvt Ltd has announced that SBI Mutual Fund, through various schemes has sold 30000 shares of Dr. Lal PathLabs Ltd, representing 0.0360% of the paid up share capital of the company on March 14, 2018.
The final holding of SBI Mutual Fund, through various schemes was 30,45,089 equity shares which is 3.6541% of the paid up share capital of the company.
Prior to the sale, the fund had 3,075,089 equity shares or 3.6901% stake in the company.
Shares of Dr. Lal PathLabs Ltd was last trading in BSE at Rs.898 as compared to the previous close of Rs. 888.75. The total number of shares traded during the day was 2020 in over 115 trades.
The stock hit an intraday high of Rs. 901.1 and intraday low of 874. The net turnover during the day was Rs. 1791331.